BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
Go back to BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.14 +0.15 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.99 | 52 Week High | $10.98 | |||
| Open | $9.04 | 52 Week Low | $1.63 | |||
| Day High | $9.34 | P/E | N/A | |||
| Day Low | $8.91 | EPS | $-0.68 | |||
| Volume | 7,405,437 | |||||
